About RONA Holdings
RONA Holdings is a venture capital firm founded in 2004. It is primarily based out of Cupertino, United States. As of Dec 2015, RONA Holdings has invested in 34 companies. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to High Tech and Life Sciences. Most recently it participated in the $***** Series B round of Atheer Overall, RONA Holdings portfolio has seen 1 unicorn, 3 IPOs and 16 acquisitions including key companies like Illumina, Adaptive Biotechnologies and Wisdo. A lot of funds co-invest with RONA Holdings, with names like FundersClub sharing a substantial percentage of its portfolio. RONA Holdings has team of 3 people including 2 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series B
Portfolio IPOs
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
RONA Holdings' List of Top Investments
RONA Holdings has a portfolio of 34 companies, one of which is a Unicorn. Their most notable investments include Illumina and Adaptive Biotechnologies.Their portfolio spans across United States and Israel. They have invested in Enterprise Applications, High Tech, Life Sciences and 15 other sectors, across stages such as Series B stage. Here is the list of top investments by RONA Holdings:1. Illumina
Developer of technologies for analysis of genetic variation and function. The company provides laboratory instruments, kits, and reagents for research, drug development, and the development of molecular tests. The product categories include gene panel and array finder, microarray kits, clinical research, and IVD products.
Key facts about Illumina
- Founded Year: 1993
- Location: San Diego (United States)
- Stage: Public
- Total Funding till date: $28M
- Employee Count: 9,630 as on Sep 30, 2026
- Investors: Gershon Capital, Quan Funds and 32 Others
- Latest Funding Round: Grant (prize money), Jan 01, 2020, $*****
- Highlight: Public
Provider of clinical diagnostics, and drug discovery for immune diseases. The company's immune profiling sequencing technology immunoSEQ enables the characterization of the immune system, helping scientists & clinicians in research and drug development. The company also offers clonoSEQ for monitoring Minimal Residual Disease (MRD) in blood-based cancers. Also, develops cell therapies, vaccines, and antibody molecules for infectious diseases.
Key facts about Adaptive Biotechnologies
- Founded Year: 2009
- Location: Seattle (United States)
- Annual Revenue: $100M - $500M as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $419M
- Employee Count: 643 as on Sep 30, 2026
- Investors: HTIF, Foresite Capital and 21 Others
- Latest Funding Round: Series F, Jan 22, 2018, $*****
- Highlight: Public
3. Wisdo
Online community platform for multiple health conditions. The platform enables users to connect, share and learn about health-related conditions and receive tips and guidance. It offers a community platform for anxiety, self-care, depression, relationship advice, cancer, diabetes, and more.
Key facts about Wisdo
- Founded Year: 2015
- Location: Ramat Hasharon (Israel)
- Stage: Acquired
- Total Funding till date: $11M
- Employee Count: 36 as on Aug 31, 2026
- Investors: For Good Ventures, RONA Holdings and 12 Others
- Latest Funding Round: Series A, Jan 06, 2023, $*****
- Highlight: Acquired
4. Parallels
Cloud based Daas platform. It provides virtualization and automation software that optimizes computing for consumers, businesses, and service providers across hardware, operating system, and virtualization platforms. It provides access software enabling remote access to computers. It includes a dashboard that provides visibility into published resources, registered users, active user sessions, and more.
Key facts about Parallels
- Founded Year: 1999
- Location: Seattle (United States)
- Stage: Acquired
- Investors: Sprout Capital Partners, Savano Capital Partners and 15 Others
- Latest Funding Round: Series B, Feb 18, 2017, $*****
- Highlight: Acquired
5. Color
Provider of end-to-end Virtual clinic offering cancer-based solutions. It assesses cancer risk, increases screening accessibility, and accelerates diagnosis. It guides patients through treatment and provides support for survivors. It offers direct care through an in house care team, including oncologists, primary care physicians, genetic counselors, and oncology-trained care advocates. It integrates with health plans and existing benefits ecosystems.
Key facts about Color
- Founded Year: 2013
- Location: Burlingame (United States)
- Valuation: $*****
- Stage: Series E
- Total Funding till date: $491M
- Employee Count: 234 as on Sep 30, 2026
- Investors: T. Rowe Price, Foresite Capital and 46 Others
- Latest Funding Round: Series E, Oct 26, 2021, $*****
- Highlight: Editors' Pick
RONA Holdings' Investments by Stage
RONA Holdings has made 2 investments in Series B stage with an average round size of $17.3M.RONA Holdings' Investments by Sector
RONA Holdings has a diverse portfolio, with companies operating in the Enterprise Applications, High Tech, Industrial Goods and Manufacturing, Internet of Things - Industry Applications and Life Sciences. Notably, it has invested in 31 Tech companies, 28 Enterprise (B2B) companies, 19 Software companies and at least 13 companies focusing on Saas.Sector | No. of Investments |
|---|---|
Enterprise Applications | 2 |
High Tech | 2 |
Industrial Goods and Manufacturing | 1 |
Internet of Things - Industry Applications | 1 |
Life Sciences | 1 |
Others | 1 |
Note: We have considered here, only first round of investments
RONA Holdings' Investments by Geography
RONA Holdings has made most investments in United States (2).RONA Holdings' recent investments
RONA Holdings has not made any investment in 2026 so far.Here are the most recent investments by RONA Holdings:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Dec 17, 2015 | United States | Series B | 3688 | [+4] | |
Dec 28, 2012 | United States | Series C | 4701 | [+6] | |
Jan 31, 2011 | United States | Series B | 2510 | [+4] |
Unicorns in RONA Holdings' Portfolio
RONA Holdings has 1 unicorn in its portfolio - Color. The most recent unicorn in their portfolio is Color which became a unicorn in 2021, 5 years before RONA Holdings first invested in it.Here is a list of unicorns in RONA Holdings' portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
66 | Provider of end-to-end Virtual clinic offering cancer-based solutions | 2013 | Burlingame | Series E | ekhlypq |
IPOs and Publicly Listed companies in RONA Holdings' Portfolio
3 of RONA Holdings' portfolio companies have become public. Adaptive Biotechnologies got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jun 2019 at marketcap of $2.42B and Webs got listed on the Bombay Stock Exchange (BSE) at marketcap of $665K.Here are RONA Holdings' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jun 27, 2019 | - | - | 4819 | |
Feb 11, 2019 | - | - | 5545 | |
Jul 28, 2000 | - | - | 9898 |
Acquired companies in RONA Holdings' Portfolio
16 companies from RONA Holdings' portfolio have been acquired. The most recent acquisition was Wisdo in Oct 2025 by Talkspace for $*****.Here are RONA Holdings' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Oct 06, 2025 | - | - | 2765 | |
Feb 20, 2024 | - | - | 6681 | |
Jun 14, 2023 | - | - | 1163 | |
Mar 02, 2022 | - | - | 3018 | |
Oct 16, 2020 | - | - | 8313 |
Team profile of RONA Holdings
RONA Holdings has a team of 3 members including 2 Partners located in United States. RONA Holdings' team does not sit on the board of any company as of now.Co-investors of RONA Holdings
Over the past 15 years, 19 investors have co-invested in RONA Holdings's portfolio companies. This includes funds and angels.
- Invested before RONA Holdings: Signature Capital, ACME and 7 others have invested in rounds before RONA Holdings. There is 1 company where Signature Capital has invested before RONA Holdings and 1 company where ACME has invested before RONA Holdings.
- Top Co-investors of RONA Holdings: 7 investors entered a company along with RONA Holdings. These include investors like FundersClub (1 company).
- Invested after RONA Holdings: A total of 3 investors have invested in RONA Holdings's portfolio after their investments. Top Investors include Square 1 Bank (1 company), EW Healthcare Partners (1 company) and Horizon (1 company).
Recent News related to RONA Holdings
•
Venture Capital Access Online | Venture Capital NewsVCA Online•Dec 17, 2015•Atheer, Streamline Ventures, Signature Capital, RONA Holdings and 3 others
•
Pioneer of Augmented Reality Computing for the Enterprise, Atheer Closes $14 Million Series B FinancingPR Newswire•Atheer, Streamline Ventures, Signature Capital, RONA Holdings and 3 others
